Fig. 12 | Scientific Reports

Fig. 12

From: Multiomics analysis reveals the involvement of NET1 in tumour immune regulation and malignant progression

Fig. 12

Mechanistic study of NET1 in TNBC cells. (A) BP and (B) KEGG enrichment analyses of DEGs in NET1-overexpressing cells compared with non-NET1-overexpressing MDA-MB-231 cells. (E) Changes in the protein levels of AKT and P-AKT (Ser473) in TNBC cell lines with and without NET1 overexpression. (D) Semiquantitative statistical analysis of the changes in AKT and P-AKT (Ser473) protein levels in TNBC cell lines with and without NET1 overexpression. (E) Changes in the protein levels of NET1 and P-AKT (Ser473) after treatment with a P-AKT inhibitor (MK2206) in SUM-159PT cells overexpressing NET1. (F) Semiquantitative statistical analysis of the changes in the protein levels of NET1 and P-AKT (Ser473) after treatment with a P-AKT inhibitor (MK2206). (G-I) CCK-8 assay of changes in the proliferation of TNBC cells with and without NET1 overexpression after treatment with a P-AKT inhibitor (MK2206). Abbreviations: BP, biological process; KEGG, Kyoto Encyclopedia of Genes and Genomes; ns, not significant, **P < 0.01, ***P < 0.001, and ****P < 0.0001.

Back to article page